Literature DB >> 24457198

Connexins, gap junctions and tissue invasion.

Norah Defamie1, Amandine Chepied2, Marc Mesnil3.   

Abstract

Formation of metastases negatively impacts the survival prognosis of cancer patients. Globally, if the various steps involved in their formation are relatively well identified, the molecular mechanisms responsible for the emergence of invasive cancer cells are still incompletely resolved. Elucidating what are the mechanisms that allow cancer cells to evade from the tumor is a crucial point since it is the first step of the metastatic potential of a solid tumor. In order to be invasive, cancer cells have to undergo transformations such as down-regulation of cell-cell adhesions, modification of cell-matrix adhesions and acquisition of proteolytic properties. These transformations are accompanied by the capacity to "activate" stromal cells, which may favor the motility of the invasive cells through the extracellular matrix. Since modulation of gap junctional intercellular communication is known to be involved in cancer, we were interested to consider whether these different transformations necessary for the acquisition of invasive phenotype are related with gap junctions and their structural proteins, the connexins. In this review, emerging roles of connexins and gap junctions in the process of tissue invasion are proposed.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Connexin; Gap junction; Invasion and tumor cell; Migration

Mesh:

Substances:

Year:  2014        PMID: 24457198     DOI: 10.1016/j.febslet.2014.01.012

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

Review 1.  How to be good at being bad: centrosome amplification and mitotic propensity drive intratumoral heterogeneity.

Authors:  Padmashree C G Rida; Guilherme Cantuaria; Michelle D Reid; Omer Kucuk; Ritu Aneja
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

2.  A phase I study of the safety and tolerability of VLX600, an Iron Chelator, in patients with refractory advanced solid tumors.

Authors:  Kabir Mody; Aaron S Mansfield; Lalitha Vemireddy; Peter Nygren; Joachim Gulbo; Mitesh Borad
Journal:  Invest New Drugs       Date:  2018-11-21       Impact factor: 3.850

3.  Cell coupling mediated by connexin 26 selectively contributes to reduced adhesivity and increased migration.

Authors:  Srikanth R Polusani; Edward A Kalmykov; Anjana Chandrasekhar; Shoshanna N Zucker; Bruce J Nicholson
Journal:  J Cell Sci       Date:  2016-10-24       Impact factor: 5.285

4.  Elevated connexin 43 expression in arsenite-and cadmium-transformed human bladder cancer cells, tumor transplants and selected high grade human bladder cancers.

Authors:  Ruowen Zhang; Liping Wang; Scott H Garrett; Donald A Sens; Jane R Dunlevy; Xu Dong Zhou; Seema Somji
Journal:  Exp Toxicol Pathol       Date:  2016-08-13

Review 5.  Desmosomes in acquired disease.

Authors:  Sara N Stahley; Andrew P Kowalczyk
Journal:  Cell Tissue Res       Date:  2015-03-21       Impact factor: 5.249

Review 6.  Gap junctions and cancer: communicating for 50 years.

Authors:  Trond Aasen; Marc Mesnil; Christian C Naus; Paul D Lampe; Dale W Laird
Journal:  Nat Rev Cancer       Date:  2016-10-21       Impact factor: 60.716

7.  Epithelial cell size dysregulation in human lung adenocarcinoma.

Authors:  Clifford W Sandlin; Song Gu; Jun Xu; Charuhas Deshpande; Michael D Feldman; Matthew C Good
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

8.  FRK inhibits migration and invasion of human glioma cells by promoting N-cadherin/β-catenin complex formation.

Authors:  Qiong Shi; Xu Song; Jun Wang; Jia Gu; Weijian Zhang; Jinxia Hu; Xiuping Zhou; Rutong Yu
Journal:  J Mol Neurosci       Date:  2014-06-27       Impact factor: 3.444

Review 9.  Mind the gap: connexins and cell-cell communication in the diabetic kidney.

Authors:  Claire E Hills; Gareth W Price; Paul E Squires
Journal:  Diabetologia       Date:  2014-10-31       Impact factor: 10.122

10.  Prognostic associations of plasma hepcidin in women with early breast cancer.

Authors:  Katarzyna J Jerzak; Ana E Lohmann; Marguerite Ennis; Elizabeta Nemeth; Tomas Ganz; Pamela J Goodwin
Journal:  Breast Cancer Res Treat       Date:  2020-09-22       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.